Investors in Rhodia hit reimbursement jackpot


Rhodia, the French specialty chemicals company, was last month forced by a group of investors, including some hedge funds led by Soros Fund Management, to reimburse a $290 million US private placement.

“By shorting the equity and going long the private placement, the hedge funds were able to play hardball and force Rhodia to take action that they did not want to do,” says Jens Jantzen, head of credit research at Bear Stearns.

The investors had been demanding early repayment of the bonds since

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options

If you already have an account, please sign in here.


Want to know what’s included in our free membership? Click here

This address will be used to create your account

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here